Tag Archives: Drug

Outgoing FDA chief Gottlieb taking drug price fight to think tank

As FDA commissioner, Scott Gottlieb battled to lower the cost of prescription drugs and streamline approval of biosimilars. Now, Gottlieb is taking that fight to the private sector. In an interview with the Washington Post, Gottlieb, who will leave the Trump administration Friday, said he plans to take a fellowship with conservative think tank American Enterprise… Read More »

FDA Approves 1st Immunotherapy Breast Cancer Drug

The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer. The combination of immunotherapy (Tecentriq) and chemotherapy (Abraxane) was given accelerated approval for triple-negative breast cancer that is locally advanced or has spread, cannot be surgically removed, and has cells that have a protein called PD-L1, CNN… Read More »